Bionano Genomics Inc expected to post a loss of 11 cents a share - Earnings Preview

Bionano Genomics

01/05/2023 14:29

* Bionano Genomics Inc  BNGO.OQ   BNGO.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 3
(estimated). 
    * The San Diego California-based  company is expected to
report  a
27.0% increase in revenue to $7.236 million from $5.7 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. The company's guidance on April 24 2023, for
the period ended March 31, was for revenue between $7.30 million
and $7.50 million.
    * ​Refinitiv's mean analyst estimate for Bionano Genomics
Inc is
for a loss of 11 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $6​, above​ its last closing price of $0.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.11       -0.11      -0.13     Missed  -18.2
 Sep. 30 2022  -0.12       -0.11      -0.11     Met     4.3
 Jun. 30 2022  -0.10       -0.09      -0.11     Missed  -20.4​
 Mar. 31 2022  -0.09       -0.07      -0.11     Missed  -46.7
 ​​Dec.        -0.06       -0.06      -0.08     Missed  -23.6
 31 2021                                                
 Sep. 30 2021  -0.06       -0.06      -0.07     Missed  -30.6​
 Jun. 30 2021  -0.05       -0.05      -0.06     Missed  -32.6
 Mar. 31 2021  -0.05       -0.04      -0.04     Met     11.1
 This summary was machine generated May 1 at 13:29 GMT.  All
figures in US dollars  unless otherwise stated